Cargando…
CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
Aluminum-containing adjuvants usually referred as Alum are considered as T helper type-2 (Th2) adjuvants, while agonists of toll-like receptors (TLRs) are viewed as adjuvants that favor Th1/Th17 immunity. Alum has been used in numerous vaccine formulations; however, its undesired pro-Th2 adjuvant ac...
Autores principales: | Mirotti, Luciana, Alberca Custódio, Ricardo Wesley, Gomes, Eliane, Rammauro, Florencia, de Araujo, Eliseu Frank, Garcia Calich, Vera Lucia, Russo, Momtchilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289984/ https://www.ncbi.nlm.nih.gov/pubmed/28220116 http://dx.doi.org/10.3389/fimmu.2017.00047 |
Ejemplares similares
-
CpG-ODN Signaling via Dendritic Cells-Expressing MyD88, but Not IL-10, Inhibits Allergic Sensitization
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021) -
Allergen-Specific Immunotherapy With Liposome Containing CpG-ODN in Murine Model of Asthma Relies on MyD88 Signaling in Dendritic Cells
por: Alberca-Custodio, Ricardo Wesley, et al.
Publicado: (2020) -
Dendritic Cells Expressing MyD88 Molecule Are Necessary and Sufficient for CpG-Mediated Inhibition of IgE Production In Vivo
por: Alberca Custodio, Ricardo W., et al.
Publicado: (2019) -
Adsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses
por: Bortolatto, Juliana, et al.
Publicado: (2015) -
The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
por: Tian, Yaomei, et al.
Publicado: (2017)